Latest Headlines

July 24, 2026

EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma

Results of the phase III EMERALD-3 trial showed that combining transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen, (single tremelimumab[an anti-cytotoxic T lymphocyte–a...

The ASCO Post

July 24, 2026

Electronic Prior Authorization Requirements for Drugs

The Association for Clinical Oncology (ASCO) submitted formal comments (see https://bit.ly/4xYRg1j) to the Centers for Medicare & Medicaid Services (CMS) in response to the 2026 CMS Interoperabili...

The ASCO Post

July 24, 2026

Neoadjuvant Inetetamab Plus Pyrotinib Evaluated in HER2-Positive Locally Advanced Breast Cancer in China

Neoadjuvant treatment with the HER2-targeted monoclonal antibody inetetamab in combination with the irreversible pan-HER tyrosine kinase inhibitor pyrotinib (inhibits HER1, HER2, HER4) and chemotherap...

The ASCO Post

July 24, 2026

Discovery Is an Act of Hope: Remembering Dr. Maura Gillison’s Pursuit of Truth

Maura Gillison did not chase awards. She chased answers, and especially clinically impactful answers. That distinction between the pursuit of recognition and the pursuit of truth defined everything ab...

The ASCO Post

July 24, 2026

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

A panel of ASCO experts voted to approve ASCO’s first guideline on ctDNA testing in patients with solid tumors or lymphoma on November 18, 2025.1 The guideline addresses four overarching clinical ques...

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

July 24, 2026

Paving New ROADS in the Treatment of Brain Metastases With Implanted Tile-Based Radiation Therapy

Tile-based radiation therapy (TBRT) implanted at the time of resection outperformed standard postoperative stereotactic radiation therapy (SRT) in the phase III Radiation One and Done Study (ROADS), i...

The ASCO Post

July 24, 2026

Access Denied: Insurance Barriers to Biomarker Testing in Lung Cancer

In the last few decades, the rapidly growing field of precision medicine has improved the survival of patients with lung cancer. Yet the benefits of these therapies do not reach all patients. Non-smal...

The ASCO Post

July 24, 2026

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

A review of the scientific literature on the impact of environmental factors on the health of pediatric cancer survivors by Omar Shakeel, MD, Assistant Professor in the Department of Pediatrics, Divis...

The ASCO Post

July 24, 2026

Palliative Care Integrated at Diagnosis Improves QOL for Patients With Breast Cancer in India

Early integration of palliative, or supportive, care at the time of breast cancer diagnosis improved quality of life more than on-demand palliative care in a randomized trial of patients in India. The...

The ASCO Post

July 24, 2026

EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma

The ASCO Post

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Latest Headlines

EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma

Electronic Prior Authorization Requirements for Drugs

Neoadjuvant Inetetamab Plus Pyrotinib Evaluated in HER2-Positive Locally Advanced Breast Cancer in China

Discovery Is an Act of Hope: Remembering Dr. Maura Gillison’s Pursuit of Truth

ASCO Publishes First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Daily News

Paving New ROADS in the Treatment of Brain Metastases With Implanted Tile-Based Radiation Therapy

Access Denied: Insurance Barriers to Biomarker Testing in Lung Cancer

Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes

Palliative Care Integrated at Diagnosis Improves QOL for Patients With Breast Cancer in India

EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

The Medicine Maker

The Analytical Scientist

Latest Headlines

Daily News

Recommendations